IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q4 2023 Holdings

Filed 2024-02-13 | 3 holdings | $148.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$125.7M2,936,50784.5%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$23.0M3,846,15415.5%
Viracta Therapeutics IncCOM92765F108$2.1K3,7000.0%